home / stock / rain / rain news

RAIN News and Press, Rain Therapeutics Inc. From 08/06/22

Stock Information
Company Name: Rain Therapeutics Inc.
Stock Symbol: RAIN
Market: NASDAQ
Website: rainthera.com
Menu
RAIN RAIN Quote RAIN Short RAIN News RAIN Articles RAIN Message Board
Get RAIN Alerts

News, Short Squeeze, Breakout and More Instantly...
RAIN - Rain Therapeutics Inc. (RAIN) Q2 2022 Earnings Call Transcript

Image source: The Motley Fool. Rain Therapeutics Inc. (NASDAQ: RAIN) Q2 2022 Earnings Call Aug 04, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: Rain Therapeutics Inc. (RAIN) Q2 2022 Earnings Call Transcript

RAIN - Rain Therapeutics GAAP EPS of -$0.66 in-line

Rain Therapeutics press release ( NASDAQ: RAIN ): Q2 GAAP EPS of -$0.66 in-line. Q2 Rain reported a net loss of $17.6 million For further details see: Rain Therapeutics GAAP EPS of -$0.66 in-line

RAIN - Rain Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Progress

– Quarter-end cash position of $105.7 million provides ample cash runway into mid-2024 – – Phase 3 MANTRA trial completed enrollment five months ahead of previous guidance; topline data anticipated in first half of 2023 – – Phase 2 MANT...

RAIN - UPDATE -- Rain Therapeutics Announces Completion of Enrollment in Phase 3 MANTRA Trial for Milademetan in Liposarcoma

– Phase 3 MANTRA trial completed enrollment five months ahead of previous guidance – – MANTRA topline data anticipated in 1H 2023 – – Management to host 2Q 2022 Earnings Call today at 5:00 PM Eastern Time – NEWARK, ...
RAIN - Rain Therapeutics Announces Completion of Enrollment in Phase 3 MANTRA Trial for Milademetan in Liposarcoma

– Phase 3 MANTRA trial completed enrollment five months ahead of previous guidance – – MANTRA topline data anticipated in 1H 2023 – – Management to host 2Q 2022 Earnings Call today at 5:00 PM Eastern Time – NEWARK, ...

RAIN - Rain Therapeutics to Report Second Quarter 2022 Financial Results and Highlights of Recent Progress on August 4, 2022

NEWARK, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Rain Therapeutics Inc. (NasdaqGS: RAIN), (“Rain”), a late-stage company developing precision oncology therapeutics, today announced it will report financial results for the second quarter ended June 30, 2022 and highlights of r...

RAIN - CLVS, OMER and ALNA among mid-day movers

Gainers: Allena Pharmaceuticals ( ALNA ) +46% . Mega Matrix ( MTMT ) +43% . Faraday Future Intelligent Electric ( FFIE ) +30% . Tyra Biosciences ( TYRA ) +29% . Omeros ( OMER ) +28% . Clovis Oncology ( CLVS ) +22% . ...
RAIN - REAL, GREE and CRMD among after hour movers

Gainers: Calithera Biosciences (CALA) +4%. Allakos (ALLK) +3%. CorMedix (CRMD) +2%. Core Scientific (CORZ) +2%. Greenidge Generation Holdings (GREE) +2%. Losers: CalAmp (CAMP) -15%. LendingTree (TREE) -14%. The RealReal (REAL) -8%. Ikena Oncology (IKNA) -6%. Rain Therapeutics (RAIN)...

RAIN - IPI, VRM and TWI among mid-day movers

Gainers: Fujian Blue Hat Interactive Entertainment Technology (BHAT) +323%. F-star Therapeutics (FSTX) +59%. Rain Therapeutics (RAIN) +43%. The9 Limited (NCTY) +36%. Vroom (VRM) +33%. MSP Recovery (MSPR) +23%. uniQure (QURE) +22%. Azure Power Global (AZRE) +22%. Valneva (VALN) +21%. Anebulo P...

RAIN - F-star, Valneva top healthcare gainers; Applied Therapeutics, Mereo lead losers' pack

Gainers: F-star Therapeutics (FSTX) +57%. Valneva (VALN) +23%. Nutriband (NTRB) +16%. Rain Therapeutics (RAIN) +15%. uniQure (QURE) +15%. Losers: Applied Therapeutics (APLT) -25%. Mereo BioPharma Group (MREO) -14%. Rigel Pharmaceuticals (RIGL) ...
Previous 10 Next 10